Modification of the tri-phasic drug release pattern of leuprolide acetate-loaded poly(lactide-co-glycolide) microparticles

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 63, Issue 2, 2006, Pages 205-214

  Luan, Xiaosong ^a   Bodmeier, Roland ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Initial release; Leuprolide acetate; Medium chain triglyceride; Polyvinylpyrrolidone; Tri phasic release

Indexed keywords

LEUPRORELIN; MEDIUM CHAIN TRIACYLGLYCEROL; NANOPARTICLE; POLYGLACTIN; POVIDONE; RESOMER; RG 503H; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; GLASS TRANSITION TEMPERATURE; MOLECULAR WEIGHT; PARAMETER; PARTICLE SIZE;

CALORIMETRY, DIFFERENTIAL SCANNING; LEUPROLIDE; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; POLYGLACTIN 910;

EID: 33646847914     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2005.12.010     Document Type: Article

References (25)

1. Ruiz J.M., and Benoît J.P. In vivo peptide release from poly(dl-lactic acid-co-glycolic acid) copolymer 50/50 microspheres. J. Control. Release 16 (1991) 177-186
2. Diwan M., and Park T.G. Pegylation enhances protein stability during encapsulation in PLGA microspheres. J. Control. Release 73 (2001) 233-244
3. Igartua M., Hernández R.M., Esquisabel A., Gascón A.R., Calvo M.B., and Pedraz J.L. Stability of BSA encapsulated into PLGA microspheres using PAGE and capillary electrophoresis. Int. J. Pharm. 169 (1998) 45-54
4. Wang J., Wang B.M., and Schwendeman S.P. Characterization of the initial burst release of a model peptide from poly(d,l-lactide-co-glycolide) microspheres. J. Control. Release 82 (2002) 289-307
5. Cleland J.L., Duenas E., Daugherty A., Marian M., Yang J., Wilson M., Celniker A.C., Shahzamani A., Quarmby V., and Chu H. Recombinant human growth hormone poly(lactic-co-glycolic acid) (PLGA) microspheres provide a long lasting effect. J. Control. Release 49 (1997) 193-205
6. Cleland J.L., Lim A., Barrón L., Duenas E.T., and Powell M.F. Development of a single-shot subunit vaccine for HIV-1: Part 4. Optimizing microencapsulation and pulsatile release of MN rgp120 from biodegradable microspheres. J. Control. Release 47 (1997) 135-150
7. Pitt C.G. The controlled parenteral delivery of polypeptides and proteins. Int. J. Pharm. 59 (1990) 173-196
8. Cohen S., Yoshioka T., Lucarelli M., Hwang L.H., and Langer R. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm. Res. 8 (1991) 713-720
9. Herrmann J., and Bodmeier R. The effect of particle microstructure on the somatostatin release from poly(lactide) microspheres prepared by a W/O/W solvent evaporation method. J. Control. Release 36 (1995) 63-71
10. Ravivarapu H.B., Lee H., and DeLuca P.P. Enhancing initial release of peptide from poly(d,l-lactide-co-glycolide) (PLGA) microspheres by addition of a porosigen and increasing drug load. Pharm. Dev. Technol. 5 (2000) 287-296
11. Husmann M., Schenderlein S., Lück M., Lindner H., and Kleinebudde P. Polymer erosion in PLGA microparticles produced by phase separation method. Int. J. Pharm. 242 (2002) 277-280
12. Okada H., Doken Y., Ogawa Y., and Toguchi H. Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers. Pharm. Res. 11 (1994) 1143-1147
13. Woo B.H., Kostanski J.W., Gebrekidan S., Dani B.A., Thanoo B.C., and DeLuca P.P. Preparation, characterization and in vivo evaluation of 120-day poly(d,l-lactide) leuprolide microspheres. J. Control. Release 75 (2001) 307-315
14. Woo B.H., Na K.H., Dani B.A., Jiang G., Thanoo B.C., and DeLuca P.P. In vitro characterization and in vivo testosterone suppression of 6-month release poly(d,l-lactide) leuprolide microspheres. Pharm. Res. 19 (2002) 546-550
15. Okada H. One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate. Adv. Drug Del. Rev. 28 (1997) 43-70
16. Kostanski J.W., Dani B.A., Schrier B., and DeLuca P.P. Effect of the concurrent LHRH antagonist administration with a LHRH superagonist in rats. Pharm. Res. 17 (2000) 445-450
17. Graham P.D., Brodbeck K.J., and McHugh A.J. Phase inversion dynamics of PLGA solutions related to drug delivery. J. Control. Release 58 (1999) 233-245
18. Ravivarapu H.B., Burton K., and DeLuca P.P. Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres. Eur. J. Pharm. Biopharm. 50 (2000) 263-270
19. Verma R.K., Kaushal A.M., and Garg S. Development and evaluation of extended release formulations of isosorbide mononitrate based on osmotic technology. Int. J. Pharm. 263 (2003) 9-24
20. Spenlehauer G., Veillard M., and Benoît J.P. Formation and characterization of cisplatin loaded poly(d,l-lactide) microspheres for chemoembolization. J. Pharm. Sci. 75 (1986) 750-755
21. Urata T., Arimori K., and Nakano M. Modification of release rates of cyclosporin A from poly(l-lactic acid) microspheres by fatty acid esters and in vivo evaluation of the microspheres. J. Control. Release 58 (1999) 133-141
22. ®) als Trägersystem für die dermale Applikation von Retinol, Department of Biology, Chemistry, Pharmacy, Freie Universität Berlin, 1999.
23. Traul K.A., Driedger A., Ingle D.L., and Nakhasi D. Review of the toxicologic properties of medium-chain triglycerides. Food Chem. Toxicol. 38 (2000) 79-98
24. Hausberger A.G., and DeLuca P.P. Characterization of biodegradable poly(d,l-lactide-co-glycolide) polymers and microspheres. J. Pharm. Biomed. Anal. 13 (1995) 747-760
25. Schlicher E.J.A.M., Postma N.S., Zuidema J., Talsma H., and Hennink W.E. Preparation and characterisation of poly(d,l-lactic-co-glycolic acid) microspheres containing desferrioxamine. Int. J. Pharm. 153 (1997) 235-245